Zheng Chai

Scientist III at Asklepios BioPharmaceuticals Inc - Durham, NC, US

Zheng Chai's Colleagues at Asklepios BioPharmaceuticals Inc
Douglas Snider

Director, Pathology and Histology

Contact Douglas Snider

Cathy Cregg

Executive Assistant to Chief Human Resources Officer & HR Coordinator

Contact Cathy Cregg

Robert Tikkanen

Research Associate II Downstream Process Development

Contact Robert Tikkanen

Venetia Leger

Research associate III

Contact Venetia Leger

View All Zheng Chai's Colleagues
Zheng Chai's Contact Details
HQ
919-561-6210
Location
Raleigh-Durham-Chapel Hill Area
Company
Asklepios BioPharmaceuticals Inc
Zheng Chai's Company Details
Asklepios BioPharmaceuticals Inc logo, Asklepios BioPharmaceuticals Inc contact details

Asklepios BioPharmaceuticals Inc

Durham, NC, US • 250 - 499 Employees
BioTech/Drugs

Asklepios BioPharmaceutical, Inc. (AskBio) is a leading clinical-stage adeno-associated virus (AAV) gene therapy company dedicated to improving the lives of patients with rare disorders and other diseases.We've built a foundation of therapeutic programs, AAV manufacturing and a rich portfolio of patented technology. Our therapeutic focus includes neuromuscular, central nervous system, cardiovascular and metabolic diseases with clinical trials underway for Pompe disease, Parkinson's disease, and congestive heart failure. Our gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid and promoter library.We became a wholly-owned, independently operated, subsidiary of Bayer AG in late 2020 as a cornerstone of its newly formed Cell & Gene Therapy (CGT) platform. Our global headquarters is in Research Triangle Park, NC. Additionally, we have significant operations in Philadelphia, PA, Columbus, OH, Scotland, France, and Spain.Vision - Pioneering science to create transformative molecular medicines.Mission - Lead innovative science and drive clinical outcomes to transform people's lives.Values:• Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need.• Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view.• Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers.• Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action.• Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what's right in every situation. Make clear commitments and follow through.

AAV Adeno-Associated Virus Gene Therapy Rare Disease Pro10 AAV Manufacturing BioTech/Drugs Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about Asklepios BioPharmaceuticals Inc
Frequently Asked Questions about Zheng Chai
Zheng Chai currently works for Asklepios BioPharmaceuticals Inc.
Zheng Chai's role at Asklepios BioPharmaceuticals Inc is Scientist III.
Zheng Chai's email address is ***@askbio.com. To view Zheng Chai's full email address, please signup to ConnectPlex.
Zheng Chai works in the BioTech/Drugs industry.
Zheng Chai's colleagues at Asklepios BioPharmaceuticals Inc are Douglas Snider, Patricia Bubacz, Cathy Cregg, Sue Stamos, Brian Blakesley, Robert Tikkanen, Venetia Leger and others.
Zheng Chai's phone number is 919-561-6210
See more information about Zheng Chai